BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16098625)

  • 1. Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma.
    Merle P; Kim M; Herrmann M; Gupte A; Lefrançois L; Califano S; Trépo C; Tanaka S; Vitvitski L; de la Monte S; Wands JR
    J Hepatol; 2005 Nov; 43(5):854-62. PubMed ID: 16098625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
    Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
    Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver.
    Giera S; Braeuning A; Köhle C; Bursch W; Metzger U; Buchmann A; Schwarz M
    Toxicol Sci; 2010 May; 115(1):22-33. PubMed ID: 20118494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells.
    Kim M; Lee HC; Tsedensodnom O; Hartley R; Lim YS; Yu E; Merle P; Wands JR
    J Hepatol; 2008 May; 48(5):780-91. PubMed ID: 18313787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the role of Wnt/beta-catenin signaling transduction pathway in hepatocellular carcinoma cell line HepG2 and L02 cell line].
    Wang QM; Jia LQ; Zhou HY; Li YS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):926-8. PubMed ID: 17908501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma.
    Merle P; de la Monte S; Kim M; Herrmann M; Tanaka S; Von Dem Bussche A; Kew MC; Trepo C; Wands JR
    Gastroenterology; 2004 Oct; 127(4):1110-22. PubMed ID: 15480989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
    Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
    Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
    Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY
    Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.
    Zucman-Rossi J; Benhamouche S; Godard C; Boyault S; Grimber G; Balabaud C; Cunha AS; Bioulac-Sage P; Perret C
    Oncogene; 2007 Feb; 26(5):774-80. PubMed ID: 16964294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
    Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
    Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H
    Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of Wnt/beta-catenin signaling transduction pathway in rat hepatocarcinogenesis].
    Wang QM; Li X; Jia LQ; Yang KM; Zhou HY; Yang HJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):454-7. PubMed ID: 16806007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells.
    Yang W; Yan HX; Chen L; Liu Q; He YQ; Yu LX; Zhang SH; Huang DD; Tang L; Kong XN; Chen C; Liu SQ; Wu MC; Wang HY
    Cancer Res; 2008 Jun; 68(11):4287-95. PubMed ID: 18519688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
    Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
    Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice.
    Apte U; Zeng G; Muller P; Tan X; Micsenyi A; Cieply B; Dai C; Liu Y; Kaestner KH; Monga SP
    Hepatology; 2006 Oct; 44(4):992-1002. PubMed ID: 17006939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
    Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
    Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms.
    Kim WB; Lewis CJ; McCall KD; Malgor R; Kohn AD; Moon RT; Kohn LD
    J Endocrinol; 2007 Apr; 193(1):93-106. PubMed ID: 17400807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.